PATENT CLAIM ANALYSIS

Application Number: 16131640
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "255050"]

Abstract:
Described herein are progestin compounds that have extended release rates and that can be used without an estrogen to produce a contraceptive state.

Claim (Index 2):
The compound of  claim 1 , wherein:\n progestin is levonorgestrel or etonogestrel; R 1 , R 2  are, independently, H, alkyl, phenyl, aryl, halogen, alkoxy, alkyl-sulfonyl or sulfonamide.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 97.0
- Lexical Diversity: 1.04348
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15685158', '14329322', '15649832', '15586710', '14932231']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7716551922581574
- 35 USC 102 Novelty (BERT): 0.5035967822628413
- Combined Prediction Score: 0.7448493512586258
- Mean Citation Score: 235.823568
- Max Citation Score: 254.91258
- Similarity Product: 184.48907370822067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test